Cargando…
Gene therapy targeting SARM1 blocks pathological axon degeneration in mice
Axonal degeneration (AxD) following nerve injury, chemotherapy, and in several neurological disorders is an active process driven by SARM1, an injury-activated NADase. Axons of SARM1-null mice exhibit greatly delayed AxD after transection and in models of neurological disease, suggesting that inhibi...
Autores principales: | Geisler, Stefanie, Huang, Shay X., Strickland, Amy, Doan, Ryan A., Summers, Daniel W., Mao, Xianrong, Park, Jiwoong, DiAntonio, Aaron, Milbrandt, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363435/ https://www.ncbi.nlm.nih.gov/pubmed/30642945 http://dx.doi.org/10.1084/jem.20181040 |
Ejemplares similares
-
NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD(+) depletion
por: Sasaki, Yo, et al.
Publicado: (2016) -
Small Molecule SARM1 Inhibitors Recapitulate the SARM1(−/−) Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate
por: Hughes, Robert O., et al.
Publicado: (2021) -
SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration
por: Ko, Kwang Woo, et al.
Publicado: (2020) -
Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients
por: Bloom, A. Joseph, et al.
Publicado: (2022) -
Distinct developmental and degenerative functions of SARM1 require NAD(+) hydrolase activity
por: Brace, E. J., et al.
Publicado: (2022)